Biote Corp Reports Q3 2026 Earnings: Revenue of $43.3M Misses Estimates, Diluted EPS of $0. ...
Procedure Revenue Declines 15.1% While Supplement Sales Grow 7.3% Related Stocks: BTMD ,
Procedure Revenue Declines 15.1% While Supplement Sales Grow 7.3% Related Stocks: BTMD ,